Skip to main content
. 2015 Dec 10;14:123. doi: 10.1186/s12937-015-0113-1

Table 2.

Sample characteristics according to the types of cancer

Type of cancer
Characteristics Total sample UGITa LGITb RSc Lung Breast Othersd
Type of cancer - n (%) 277 (100) 43 (15.5) 58 (20.9) 52 (18.8) 32 (11.6) 30 (10.8) 62 (22.4)
Age - Mean (SD) 54.7 (14.9) 57.6(13.3) 57.6 (12.9) 52.9 (15.3) 57.7 (13.8) 56.6 (15.5) 48.8 (16.2)
 ≥60 - n (%) 109 (39.4) 20 (18.3) 29 (26.6) 19 (17.4) 13 (11.9) 12 (11.0) 16 (14.7)
Gender - n (%)
 Male 122 (44.0) 23 (18.9) 20 (16.4) 15 (12.3) 21 (17.2) 0 (0.0) 43 (35.2)
 Female 155 (56.0) 20 (12.9) 38 (24.5) 37 (23.9) 11 (7.1) 30 (19.4) 19 (12.3)
Metastasis - n (%)
 Absent 138 (49.8) 15 (10.9) 29 (21.0) 26 (18.8) 11 (8.0) 19 (13.8) 38 (27.5)
 Present 139 (50.2) 28 (20.1) 29 (20.9) 26 (18.7) 21 (15.1) 11 (7.9) 24 (17.3)
Performance status - n (%)
 <2 149 (53.8) 20 (13.4) 36 (24.2) 23 (15.4) 14 (9.4) 17 (11.4) 39 (26.2)
 ≥2 128 (46.2) 23 (18.0) 22 (17.2) 29 (22.7) 18 (14.1) 13 (10.2) 23 (18.0)
Symptoms of impact - n (%)
 Yes 186 (67.1) 31 (16.7) 35 (18.8) 39 (21.0) 26 (14.0) 17 (9.1) 38 (20.4)
 No 91 (32.9) 12 (13.2) 23 (25.3) 13 (14.3) 6 (6.6) 13 (14.3) 24 (26.4)
%WL ≥5 em 6 meses - n (%)
 Yes 101 (80.2) 20 (19.8) 21 (20.8) 15 (14.9) 15 (14.9) 5 (5.0) 25 (24.8)
 No 25 (19.8) 2 (8.0) 5 (20.0) 7 (28.0) 1 (4.0) 4 (16.0) 6 (24.0)
Overweight (pBMI) - n (%)
 Yes 76 (60.3) 14 (18.4) 12 (15.8) 15 (19.7) 12 (15.8) 4 (5.3) 19 (25.0)
 No 50 (39.7) 8 (16.0) 14 (28.0) 7 (14.0) 4 (8.0) 5 (10.0) 12 (24.0)
PG-SGA - n (%)
 Well nourished 80 (28.9) 7 (8.8) 19 (23.8) 13 (16.3) 5 (6.3) 13 (16.3) 23 (28.8)
 Moderate malnutrition 98 (35.4) 8 (8.2) 21 (21.4) 21 (21.4) 17 (17.3) 12 (12.2) 19 (19.4)
 Severe malnutrition 99 (35.7) 28 (28.3) 18 (18.2) 18 (18.2) 10 (10.1) 5 (5.1) 20 (20.2)

SD standard deviation, PS performance status, %WL weight loss percentage, PG-SGA patient-generated subjective global assessment; aUpper gastrointestinal tract: esophagus, stomach, pancreas, liver, gallbladder, biliary ducts; bLower gastrointestinal tract: colon, rectum and anal canal; cReproductive system: ovarian, cervical, testicular and prostate; dHead and neck, hematological, unknown primary site, sarcoma, melanoma